Anika Therapeutics
ANIK
164 hedge funds and large institutions have $613M invested in Anika Therapeutics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 69 reducing their positions, and 15 closing their positions.
2,976% more call options, than puts
Call options by funds: $22.9M | Put options by funds: $746K
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
27% more capital invested
Capital invested by funds: $481M → $613M (+$132M)
5% more funds holding
Funds holding: 156 → 164 (+8)
0.49% less ownership
Funds ownership: 95.71% → 95.22% (-0.49%)
41% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 69
Top Buyers
Top Sellers
| 1 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$3.91M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.71M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.68M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.9M |
| 5 |
SG Americas Securities
New York
|
-$1.48M |
ANIK Hedge Fund Activity: Q4 2020 in Review
164 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2020, worth a combined $613M — up 27% from $481M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ANIK positions and 15 closed out — a net gain of 8 holders — while 41 added to existing stakes and 69 trimmed.
The largest buyer was Avidity Partners Management, adding an estimated $4.91M. The largest seller was Baird Financial Group, cutting an estimated $3.91M.
- 164 institutional investors held Anika Therapeutics (ANIK) as of Q4 2020, up from 156 in Q3 2020.
- Funds reported $613M of Anika Therapeutics stock for Q4 2020, up 27% quarter-over-quarter.
- 23 funds opened new Anika Therapeutics positions in Q4 2020 and 15 closed out, a net change of +8 holders.
- The largest Anika Therapeutics buyer in Q4 2020 was Avidity Partners Management, an estimated $4.91M added.
- The largest Anika Therapeutics seller in Q4 2020 was Baird Financial Group, an estimated $3.91M sold.
Based on aggregated 13F filings for Q4 2020.